This funding marks a pivotal moment in Nuritas’ mission to improve the lives of billions by redefining the future of health and nutrition through groundbreaking ingredient innovation.
The round was led by M&G Investments, on behalf of its Catalyst strategy — a purpose-led initiative supporting transformative businesses addressing global social and environmental challenges.
McWin Capital Partners, a private equity and venture capital firm focused on high-growth companies in the food ecosystem, also joined as a key investor, further solidifying Nuritas’ foundation for global expansion. Current investors Grosvenor and ECBF also participated in the round.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Nutraceutical Business Review.
Subscribe now Already a subscriber? Sign in here.